Medications for adults with type 2 diabetes: a living systematic review and network meta-analysis
This article is the first version of a living systematic review. It is linked to a living <i>BMJ</i> Rapid Recommendation and other living clinical practice guidelines, presenting risk stratified recommendations for patients with type 2 diabetes at lower, moderate, and higher risk of cardiovascular and kidney complications. The latest evidence will be made available via the <i>BMJ</i> Rapid Recommendation and via an interactive GRADE evidence summary (MATCH-IT: https://matchit.magicevidence.org/250709dist-diabetes/#!/). Major updates will be published in <i>The BMJ</i>.
Authors
- Frank C. Brosius (ORCID: https://orcid.org/0000-0002-4244-8335)
- Heath White (ORCID: https://orcid.org/0000-0002-4147-5278)
- Feng Sun (ORCID: https://orcid.org/0000-0003-4334-6805)
- Thomas Agoritsas (ORCID: https://orcid.org/0000-0002-6182-9969)
- Changhai Liu (ORCID: https://orcid.org/0000-0002-0551-6482)
- Oliver Schnell (ORCID: https://orcid.org/0000-0003-4968-2367)
- Yunhe Mao (ORCID: https://orcid.org/0000-0002-1731-3586)
- Tari Turner (ORCID: https://orcid.org/0000-0002-7990-1623)
- Per Olav Vandvik (ORCID: https://orcid.org/0000-0001-8958-2710)
- Nikolaus Marx (ORCID: https://orcid.org/0000-0001-6141-634X)
- Arnav Agarwal (ORCID: https://orcid.org/0000-0002-0931-7851)
- Xinyu Zou (ORCID: https://orcid.org/0000-0002-4582-5992)
- Yiyuan Gao (ORCID: https://orcid.org/0000-0002-3090-8912)
- Qinlin Fan
- Yu Gan (ORCID: https://orcid.org/0000-0002-5769-6809)
- Matthew Quigley (ORCID: https://orcid.org/0000-0002-5871-8993)
- Lars Rydén (ORCID: https://orcid.org/0000-0002-5430-4697)
- Xiaohui Pan (ORCID: https://orcid.org/0000-0002-9001-1728)
- Chunjuan Zhai (ORCID: https://orcid.org/0000-0002-2953-7907)
- Xin Tian (ORCID: https://orcid.org/0000-0003-1896-2462)
- Britta Tendal Jeppesen
- Qingyang Shi (ORCID: https://orcid.org/0000-0003-4299-5889)
- Qiang Li (ORCID: https://orcid.org/0000-0002-9724-5439)
- Steve McDonald (ORCID: https://orcid.org/0000-0003-2832-5205)
- Tanya Millard (ORCID: https://orcid.org/0000-0001-7135-3231)
- Helen Macdonald (ORCID: https://orcid.org/0000-0001-8755-9314)
- Zhiming Zhu (ORCID: https://orcid.org/0000-0003-1035-5588)
- Eberhard Standl (ORCID: https://orcid.org/0000-0002-8667-633X)
- Sheyu Li (ORCID: https://orcid.org/0000-0003-0060-0287)
- Yanyan Wang (ORCID: https://orcid.org/0000-0002-9888-9850)
- Jing An (ORCID: https://orcid.org/0000-0002-2567-0380)
- Chi Yuan (ORCID: https://orcid.org/0000-0002-4605-8123)
- Gordon H. Guyatt
- Yinghui Jin (ORCID: https://orcid.org/0000-0003-4725-9581)
- Barbara White
- Kailei Nong
Institutions
- University of Arizona (US)
- The Tavistock and Portman NHS Foundation Trust (GB)
- Army Medical University (CN)
- University of Alberta (CA)
- University of Groningen (NL)
- Peking University (CN)
- Sichuan University (CN)
- Karolinska Institutet (SE)
- Helmholtz Zentrum München (DE)
- Wuhan University (CN)
- West China Hospital of Sichuan University (CN)
- Australian Diabetes Society (AU)
- Daping Hospital (CN)
- Lovisenberg Diakonale Høgskole (NO)
- University Hospital of Geneva (CH)
- Shandong Provincial Hospital (CN)
- Zero to Three (US)
- Zhongnan Hospital of Wuhan University (CN)
- Universitätsklinikum Aachen (DE)
- Hypertension Institute (US)
- Impact (CA)
- Tris Pharma (United States) (US)
- Shandong First Medical University (CN)
- State Key Laboratory of Biotherapy
- Monash University (AU)
- RWTH Aachen University (DE)
- Tavistock Institute (GB)
- McMaster University (CA)
Publication Details
- Journal
- BMJ
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1136/bmj-2024-083039
- Citations
- 18
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 23.31
Funders
- Eli Lilly and Company
- AstraZeneca
- Bayer
- Sanofi
- Gilead Sciences
- MannKind Corporation
- Deutsche Forschungsgemeinschaft
- National Natural Science Foundation of China
- Novo Nordisk
- Stockholms Läns Landsting
- Sichuan University
- Lilly Deutschland
- National Institutes of Health
- Abbott Diagnostics
- West China Hospital, Sichuan University